MicroRNA expression and virulence in pandemic influenza virus-infected mice.
The worst known H1N1 influenza pandemic in history resulted in more than 20 million deaths in 1918 and 1919. Although the underlying mechanism causing the extreme virulence of the 1918 influenza virus is still obscure, our previous functional genomics analyses revealed a correlation between the lethality of the reconstructed 1918 influenza virus (r1918) in mice and a unique gene expression pattern associated with severe immune responses in the lungs. Lately, microRNAs have emerged as a class of crucial regulators for gene expression. To determine whether differential expression of cellular microRNAs plays a role in the host response to r1918 infection, we compared the lung cellular "microRNAome" of mice infected by r1918 virus with that of mice infected by a nonlethal seasonal influenza virus, A/Texas/36/91. We found that a group of microRNAs, including miR-200a and miR-223, were differentially expressed in response to influenza virus infection and that r1918 and A/Texas/36/91 infection induced distinct microRNA expression profiles. Moreover, we observed significant enrichment in the number of predicted cellular target mRNAs whose expression was inversely correlated with the expression of these microRNAs. Intriguingly, gene ontology analysis revealed that many of these mRNAs play roles in immune response and cell death pathways, which are known to be associated with the extreme virulence of r1918. This is the first demonstration that cellular gene expression patterns in influenza virus-infected mice may be attributed in part to microRNA regulation and that such regulation may be a contributing factor to the extreme virulence of the r1918.
Li
Yu
Y
Department of Microbiology, University of Washington, Seattle, WA 98195-8070, USA.
Chan
Eric Y
EY
Li
Jiangning
J
Ni
Chester
C
Peng
Xinxia
X
Rosenzweig
Elizabeth
E
Tumpey
Terrence M
TM
Katze
Michael G
MG
D000818:Animals; D017362:Cyclic AMP Response Element-Binding Protein / Q000378:metabolism; D004196:Disease Outbreaks; D020869:Gene Expression Profiling; D005786:Gene Expression Regulation; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000235:genetics / Q000276:immunology / Q000472:pathogenicity*; D007251:Influenza, Human / Q000453:epidemiology* / Q000276:immunology / Q000821:virology; D007370:Interferon Type I / Q000276:immunology; D008168:Lung / Q000276:immunology / Q000502:physiology / Q000821:virology; D051379:Mice; D035683:MicroRNAs / Q000235:genetics / Q000276:immunology*; D020411:Oligonucleotide Array Sequence Analysis; D009975:Orthomyxoviridae / Q000235:genetics / Q000276:immunology / Q000472:pathogenicity*; D009976:Orthomyxoviridae Infections / Q000453:epidemiology* / Q000276:immunology / Q000821:virology
D017362:Cyclic AMP Response Element-Binding Protein; D007370:Interferon Type I; C544877:MIRN223 microRNA, mouse; D035683:MicroRNAs; C543719:Mirn200 microRNA, mouse